Skip to main content

$0.003 -0.001

High

$0.00

Low

$0.00

Trades

1

Turnover

$54

Volume

21,427
30 June 2023 at 2:30pm
Register to track ADR and receive email alerts.

Adherium to support Avillion sponsored clinical study

StockBot

416,823 posts

ADR released this announcement to the ASX on 2 June 2022, 9:36. The announcement is marked as price sensitive, and is 3 page(s) in length and 135.98kb in size.

You can view all announcements from ADR and see how they appear on a price chart on the announcements page.

At the date of this announcement, ADR was 0.200% short sold according to ASIC data. It was ranked the 406th most shorted stock on the ASX. It remains ranked 406th as of the latest reported data (14 February 2023).

Other Recent Announcements from ADR
Application for quotation of securities - ADR 28 June 2023, 16:25
Change of Auditor 27 June 2023, 9:41
Notification of cessation of securities - ADR 11 May 2023, 13:49
Adherium to support Avillion sponsored clinical study 2 June 2022, 9:36
Adherium Senior Management Update 30 May 2022, 10:01
Adherium Exhibiting at ATS 2022 13 May 2022, 10:48
Quarterly Activities/Appendix 4C Cash Flow Report 29 April 2022, 12:43
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track ADR and receive email alerts.